ABSTRACT
Objective The objective of this study is to determine the prevalence of abdominal obesity and its associated factors in Burkina Faso. We hypothesize that there is a high burden of abdominal obesity and it is significantly associated with sociodemographic and cardiovascular risk factors.
Design We performed secondary analysis of the survey conducted in Burkina Faso using the World Health Organization (WHO) STEPwise approach.
Setting The study was conducted in Burkina Faso with all 13 regions of the country included.
Participants Our study involved 4308 adults of both sexes aged 25 to 64 years.
Main outcome Our primary outcome was the abdominal obesity which was could defined using a cut-off point of waist circumference (WC) of ≥94 cm for men and ≥80 cm for women.
Results The overall age-standardized prevalence of abdominal obesity was 22.5% (95% CI: 21.3–23.7). This age-standardized prevalence was 35.9% (95% CI: 33.9–37.9) among women and 5.2% (95% CI: 4.3–6.2) among men (p < 0.001). In urban areas, the age-standardized prevalence of abdominal obesity was 42.8% (95% CI: 39.9–45.7) and 17.0% (95%CI: 15.7–18.2) in rural areas (p < 0.001). The overall age-standardized prevalence of very high WC (WC ≥102 cm for men and ≥88 cm for women) was 10.2% (95%CI: 9.3–11.1). According to the National Institute for Health and Clinical Excellence (NICE) BMI–WC matrix, which combines the body mass index (BMI) and WC to define different levels of cardiovascular health risk, 14.6% of adult Burkinabè had an increased cardiovascular health risk.
Conclusion Our study shows a high prevalence of abdominal obesity among the adult population in Burkina Faso. These findings suggest that the measurement of WC should be systematically incorporated in Burkina Faso primary healthcare centers for the early detection of high cardiovascular risk in order to reduce levels of premature death.
STRENGTHS AND LIMITATIONS OF THIS STUDY
➢ This is the first national representative study on abdominal obesity in the context of an emerging epidemiological transition in Burkina Faso.
➢ A recommended cut-off point was used to define abdominal obesity among the adult population in Burkina Faso, which we found to be associated with “intermediate” cardiovascular risk factors.
➢ The waist circumference and risk factors used in this study were measured using the standard approach proposed by the WHO [1]. However, some risk factors such as physical inactivity, alcohol consumption, and type of fat were self-reported and may therefore be affected by information bias.
➢ This study was a cross-sectional study and must not be considered to make causal inference.
Target journal https://bmjopen.bmj.com/
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Academie de Recherche e de l'Enseignement Superieur (ARES) of Belgium, in the context of a research program for development focused on the cardiovascular diseases at Burkina Faso. The projet CARDIOPEV is being conducted by the Institut de recherche en science de la sante (IRSS) in Burkina Faso and Universite Libre de Bruxelles in Belgium.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Research was approuved by the national ethic committee of health research of Burkina Faso (number of approval: Deliberation No. 2012-12-092 of December, 05, 2012)
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The dataset of the STEPS survey that was used in this research is available at the Ministry of Health upon request to Bicaba Brice: bicaba_brico{at}yahoo.fr or Zoma Torez : torezo2000{at}yahoo.fr). All survey materials are available on the WHO website (https://extranet.who.int/ncdsmicrodata/index.php/catalog)
